drugset / Trial / NCT01497535

Within-subject Variability of Insulin Detemir in Healthy Volunteers

NCT01497535

Phase 1 Completed 40 enrolled Novo Nordisk A/S
RandomizedParallel-groupDouble-blindTreatment

Summary

This trial is conducted in Europe. The aim of this trial is to compare the within-subject variability of insulin detemir to that of another basal insulin analogue, insulin glargine in healthy volunteers.

Timeline

Start
2004-05-27
Primary completion
2004-10-31
Completion
2004-10-31

Drugs

EvaluationDrugModalityDoseRoute
Subject insulin detemir Protein / enzyme biologic 0.4 iu/kg Subcutaneous
Comparator insulin glargine Protein / enzyme biologic 0.4 iu/kg Subcutaneous

Indications